Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice. 2007

Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
University Medical Center Groningen, University of Groningen, Groningen, The Netherlands. m.van.amerongen@med.umcg.nl

Macrophages have been suggested to be beneficial for myocardial wound healing. We investigated the role of macrophages in myocardial wound healing by inhibition of macrophage infiltration after myocardial injury. We used a murine cryoinjury model to induce left ventricular damage. Infiltrating macrophages were depleted during the 1st week after cryoinjury by serial intravenous injections of clodronate-containing liposomes. After injury, the presence of macrophages, which secreted high levels of transforming growth factor-beta and vascular endothelial growth factor-A, led to rapid removal of cell debris and replacement by granulation tissue containing inflammatory cells and blood vessels, followed by myofibroblast infiltration and collagen deposition. In macrophage-depleted hearts, nonresorbed cell debris was still observed 4 weeks after injury. Secretion of transforming growth factor-beta and vascular endothelial growth factor-A as well as neovascularization, myofibroblast infiltration, and collagen deposition decreased. Moreover, macrophage depletion resulted in a high mortality rate accompanied by increased left ventricular dilatation and wall thinning. In conclusion, infiltrating macrophage depletion markedly impairs wound healing and increases remodeling and mortality after myocardial injury, identifying the macrophage as a key player in myocardial wound healing. Based on these findings, we propose that increasing macrophage numbers early after myocardial infarction could be a clinically relevant option to promote myocardial wound healing and subsequently to reduce remodeling and heart failure.

UI MeSH Term Description Entries
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D003331 Coronary Vessels The veins and arteries of the HEART. Coronary Arteries,Sinus Node Artery,Coronary Veins,Arteries, Coronary,Arteries, Sinus Node,Artery, Coronary,Artery, Sinus Node,Coronary Artery,Coronary Vein,Coronary Vessel,Sinus Node Arteries,Vein, Coronary,Veins, Coronary,Vessel, Coronary,Vessels, Coronary
D006335 Heart Injuries General or unspecified injuries to the heart. Cardiac Rupture, Traumatic,Heart Rupture, Traumatic,Injuries, Heart,Cardiac Ruptures, Traumatic,Heart Injury,Heart Ruptures, Traumatic,Injury, Heart,Rupture, Traumatic Cardiac,Rupture, Traumatic Heart,Ruptures, Traumatic Cardiac,Ruptures, Traumatic Heart,Traumatic Cardiac Rupture,Traumatic Cardiac Ruptures,Traumatic Heart Rupture,Traumatic Heart Ruptures
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014945 Wound Healing Restoration of integrity to traumatized tissue. Healing, Wound,Healings, Wound,Wound Healings
D042461 Vascular Endothelial Growth Factor A The original member of the family of endothelial cell growth factors referred to as VASCULAR ENDOTHELIAL GROWTH FACTORS. Vascular endothelial growth factor-A was originally isolated from tumor cells and referred to as "tumor angiogenesis factor" and "vascular permeability factor". Although expressed at high levels in certain tumor-derived cells it is produced by a wide variety of cell types. In addition to stimulating vascular growth and vascular permeability it may play a role in stimulating VASODILATION via NITRIC OXIDE-dependent pathways. Alternative splicing of the mRNA for vascular endothelial growth factor A results in several isoforms of the protein being produced. Vascular Endothelial Growth Factor,Vascular Endothelial Growth Factor-A,GD-VEGF,Glioma-Derived Vascular Endothelial Cell Growth Factor,VEGF,VEGF-A,Vascular Permeability Factor,Vasculotropin,Glioma Derived Vascular Endothelial Cell Growth Factor,Permeability Factor, Vascular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
January 2013, PloS one,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
October 2014, International journal of cardiology,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
January 2007, Circulation,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
December 2009, Interactive cardiovascular and thoracic surgery,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
November 1995, Cardiologia (Rome, Italy),
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
May 1992, Archives des maladies du coeur et des vaisseaux,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
February 2005, Circulation,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
May 2003, Circulation,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
March 2006, Circulation,
Machteld J van Amerongen, and Martin C Harmsen, and Nico van Rooijen, and Arjen H Petersen, and Marja J A van Luyn
April 2019, Circulation research,
Copied contents to your clipboard!